Keyphrases
Acute Kidney Injury
88%
Alemtuzumab
66%
Antihypertensive Drugs
66%
Atypical Hemolytic Uremic Syndrome (aHUS)
66%
Atypical Presentation
66%
Cardiovascular Disease
33%
Clinical Decisions
66%
Clinical Judgment
66%
Clinical Trials
33%
Diabetic Nephropathy
66%
Diagnostic Challenge
22%
Donation after Cardiac Death
66%
Drug Trials
33%
During Pregnancy
22%
Eculizumab
22%
Elevated Liver Enzymes
22%
High Blood Pressure
66%
International Survey
66%
Joint National Committee
66%
Kidney Transplantation
100%
Kinetic Estimated Glomerular Filtration Rate
66%
Lifestyle Modification
66%
Liver Transplantation
66%
Measured Creatinine Clearance
66%
Medical Care
66%
Membrane Attack Complex
22%
Membranous Nephropathy
66%
Meta-analysis
66%
Nephrologists
66%
Novel Therapies
33%
Pancreas Transplant Alone
40%
Patient Survival
25%
Patients with Hypertension
66%
Postpartum Period
44%
Preeclampsia
66%
Pregnancy Disorders
66%
Principal Investigator
33%
Randomized Controlled Trial
66%
Renal Denervation
33%
Renal Outcome
33%
Resistant Hypertension
66%
Steroid-free
66%
Systematic Meta-analysis
66%
Take-home
66%
Thrombocytopenia
44%
Thrombotic Microangiopathy
66%
Trial Data
66%
Type 2 Diabetes Mellitus (T2DM)
33%
Type 2 Diabetic Patients
33%
Young Women
22%
Medicine and Dentistry
Acute Kidney Injury
88%
Antibodies
6%
Atypical Hemolytic Uremic Syndrome
66%
Bacterial Infection
6%
Cardiovascular Disease
33%
Chronic Kidney Disease
10%
Clinical Significance
22%
Clinical Trial
33%
Complement Membrane Attack Complex
22%
Delayed Diagnosis
22%
Delayed Graft Function
8%
Demography
10%
Diabetic Nephropathy
66%
Diagnosis
22%
Diseases
27%
Drug Screening
33%
Drug Therapy
33%
Eclampsia
22%
Eclampsia and Preeclampsia
22%
Eculizumab
22%
Elevated Transaminases
22%
Graft Survival
26%
Hypertension
66%
Immunosuppressive Treatment
66%
Kidney Denervation
33%
Kidney Transplantation
60%
Lifestyle Modification
66%
Maturity Onset Diabetes of the Young
33%
Medical Care
66%
Membranous Glomerulonephritis
66%
Meta-Analysis
66%
Microangiopathy
66%
Nephrologist
66%
Observational Study
66%
Pancreas Transplantation
66%
Pathophysiology
22%
Patient with Hypertension
66%
Patient with Type 2 Diabetes
33%
Platelet
22%
Pre-Eclampsia
22%
Puerperium
44%
Randomized Controlled Trial
66%
Renal Failure
22%
Renal Replacement Therapy
10%
Resistant Hypertension
66%
Single Drug Dose
66%
Systematic Review
66%
Thrombocytopenia
44%
Thrombotic Thrombocytopenic Purpura
22%
Transplantation
13%